相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An oral first-in-class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer
Miho Ushijima et al.
CANCER SCIENCE (2022)
MAPK-Activated Protein Kinases: Servant or Partner?
Natalia Ronkina et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2022)
Simultaneous Targeting of RSK and AKT Efficiently Inhibits YB-1-Mediated Repair of Ionizing Radiation-Induced DNA Double-Strand Breaks in Breast Cancer Cells
Konstanze Lettau et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
MEK inhibitor resistance mechanisms and recent developments in combination trials
E. Kun et al.
CANCER TREATMENT REVIEWS (2021)
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
Theresa E. Hickey et al.
NATURE MEDICINE (2021)
Sustained ERK1/2 signaling is necessary for follicular rupture during ovulation in mice
Ejimedo Madogwe et al.
REPRODUCTION (2021)
A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor
Yongjian Huang et al.
ELIFE (2021)
G protein-coupled estrogen receptor 1: a novel target to treat cardiovascular disease in a sex-specific manner?
Quynh Nhu Dinh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance
Yichen Xu et al.
CELL (2021)
Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer
Derek K. Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Menopausal hormone therapy and women's health: An umbrella review
Guo-Qiang Zhang et al.
PLOS MEDICINE (2021)
A Novel Protein-Protein Interaction between RSK3 and IκBα and a New Binding Inhibitor That Suppresses Breast Cancer Tumorigenesis
Hee-Sub Yoon et al.
CANCERS (2021)
RASopathies: From germline mutations to somatic and multigenic diseases
Quentin Riller et al.
BIOMEDICAL JOURNAL (2021)
Identifying requirements for RSK2 specific inhibitors
Eric B. Wright et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
The plasticity of mRNA translation during cancer progression and therapy resistance
Lucilla Fabbri et al.
NATURE REVIEWS CANCER (2021)
The MEK/ERK Network as a Therapeutic Target in Human Cancer
Renee Barbosa et al.
MOLECULAR CANCER RESEARCH (2021)
A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors
Andrea Varga et al.
CLINICAL CANCER RESEARCH (2020)
Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
Lidia Moyano-Galceran et al.
EMBO MOLECULAR MEDICINE (2020)
Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance
Tomohiro Shibata et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors
Macus Tien Kuo et al.
TRANSLATIONAL ONCOLOGY (2020)
Enhanced JunD/RSK3 signalling due to loss of BRD4/FOXD3/miR-548d-3p axis determines BET inhibition resistance
Fang Tai et al.
NATURE COMMUNICATIONS (2020)
Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects
Angela Tomasovic et al.
NATURE COMMUNICATIONS (2020)
ERK signalling: a master regulator of cell behaviour, life and fate
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha
Katarzyna A. Ludwik et al.
CELL REPORTS (2020)
Oestradiol as a neuromodulator of learning and memory
Lisa R. Taxier et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
Rahul Mal et al.
FRONTIERS IN ONCOLOGY (2020)
Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer
Michihiko Kuwano et al.
CANCER SCIENCE (2019)
Targeting ERK beyond the boundaries of the kinase active site in melanoma
Rachel M. Sammons et al.
MOLECULAR CARCINOGENESIS (2019)
Extracellular Signal-Regulated Kinase: A Regulator of Cell Growth, Inflammation, Chondrocyte and Bone Cell Receptor-Mediated Gene Expression
Nathan Lu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Estrogen-Receptor Expression and Function in Female Reproductive Disease
Zi-Run Tang et al.
CELLS (2019)
First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study
Ryan J. Sullivan et al.
CANCER DISCOVERY (2018)
Rapid estrogen receptor-alpha signaling mediated by ERK activation regulates vascular tone in male and ovary-intact female mice
Seong Chul Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Estrogen: The necessary evil for human health, and ways to tame it
Seema Patel et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
ERα-Mediated Nuclear Sequestration of RSK2 Is Required for ER+ Breast Cancer Tumorigenesis
Katarzyna A. Ludwik et al.
CANCER RESEARCH (2018)
Expression patterns of STAT3, ERK and estrogen-receptor alpha are associated with development and histologic severity of hepatic steatosis: a retrospective study
Euno Choi et al.
DIAGNOSTIC PATHOLOGY (2018)
Estrogen Receptors: New Directions in the New Millennium
Sylvia C. Hewitt et al.
ENDOCRINE REVIEWS (2018)
YBX1 at the crossroads of non-coding transcriptome, exosomal, and cytoplasmic granular signaling
Padmanaban S. Suresh et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2018)
High nuclear MSK1 is associated with longer survival in breast cancer patients
Xuan Pu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Signaling Pathways Involved in the Regulation of mRNA Translation
Philippe P. Roux et al.
MOLECULAR AND CELLULAR BIOLOGY (2018)
Defining the role of the RSK isoforms in cancer
Thibault Houles et al.
SEMINARS IN CANCER BIOLOGY (2018)
Animal Models for Coffin-Lowry Syndrome: RSK2 and Nervous System Dysfunction
Matthias Fischer et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2018)
Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38 alpha
Ivan del Barco Barrantes et al.
STEM CELL REPORTS (2018)
N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure
Yukitomo Arao et al.
MOLECULAR METABOLISM (2018)
High prevalence of syndromic disorders in patients with non-isolated central precocious puberty
Selmen Wannes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Sex- and Age-Specific Impact of ERK Loss Within the Pituitary Gonadotrope in Mice
Jessica L. Brown et al.
ENDOCRINOLOGY (2018)
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors
Stergios J. Moschos et al.
JCI INSIGHT (2018)
A compendium of ERK targets
Evrim B. Uenal et al.
FEBS LETTERS (2017)
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming
Phillip A. Geter et al.
GENES & DEVELOPMENT (2017)
Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis
Outi Uimari et al.
HUMAN REPRODUCTION (2017)
Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in KRAS-Mutant NSCLC Is Mediated via Reactivation of the ERK-p90RSK-mTOR Signaling Network
Suman Chatterjee et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Divergent effects of intrinsically active MEK variants on developmental Ras signaling
Yogesh Goyal et al.
NATURE GENETICS (2017)
Mouse models to evaluate the role of estrogen receptor in skeletal maintenance and adaptation
Amanda M. Rooney et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics
Daniel M. Freed et al.
CELL (2017)
Selective Activation of Estrogen Receptor α Activation Function-1 Is Sufficient to Prevent Obesity, Steatosis, and Insulin Resistance in Mouse
Maeva Guillaume et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study
Meral Gunaldi et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2016)
Feedback activation of neurofibromin terminates growth factor-induced Ras activation
Anne Hennig et al.
CELL COMMUNICATION AND SIGNALING (2016)
Negative feedback regulation of the ERK1/2 MAPK pathway
David Lake et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Ribosomal S6 kinase (RSK) modulators: a patent review
Katarzyna A. Ludwik et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line
Annette Lasham et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer
Katarzyna A. Ludwik et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The PDK1-Rsk Signaling Pathway Controls Langerhans Cell Proliferation and Patterning
Rossana Zaru et al.
JOURNAL OF IMMUNOLOGY (2015)
Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells
Alastair H. Davies et al.
ONCOTARGET (2015)
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road
Christopher J. Caunt et al.
NATURE REVIEWS CANCER (2015)
17β-Estradiol Replacement Reverses Age-Related Lung Disease in Estrogen-Deficient C57BL/6J Mice
Marilyn K. Glassberg et al.
ENDOCRINOLOGY (2014)
Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins
D. Reyes et al.
ONCOGENE (2014)
RSK2 Is a Modulator of Craniofacial Development
Virginie Laugel-Haushalter et al.
PLOS ONE (2014)
Phosphorylation releases constraints to domain motion in ERK2
Yao Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
GPER Mediates Estrogen-Induced Signaling and Proliferation in Human Breast Epithelial Cells and Normal and Malignant Breast
Allison L. Scaling et al.
HORMONES & CANCER (2014)
Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway
Yue-Hua Yang et al.
APOPTOSIS (2013)
The role of estrogen receptor α in the regulation of bone and growth plate cartilage
A. E. Borjesson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer
Violeta Serra et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Gab2 Phosphorylation by RSK Inhibits Shp2 Recruitment and Cell Motility
Xiaocui Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation
Madhurima Saha et al.
BIOCHEMICAL JOURNAL (2012)
Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
Hyeong-Gon Moon et al.
BMC CANCER (2012)
Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion
Hung-Ming Lam et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
Marie Cargnello et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2011)
ESTRADIOL-17β-RESPONSIVE A1 AND A2 NORADRENERGIC CELLS OF THE BRAIN STEM PROJECT TO BED NUCLEUS OF THE STRIA TERMINALIS IN THE EWE BRAIN: A POSSIBLE ROUTE FOR REGULATION OF GONADOTROPIN RELEASING HORMONE CELLS
A. Pereira et al.
NEUROSCIENCE (2010)
Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer
Hiroko Yamashita et al.
CANCER SCIENCE (2009)
MAPK3/1 (ERK1/2) in Ovarian Granulosa Cells Are Essential for Female Fertility
Heng-Yu Fan et al.
SCIENCE (2009)
Expression of HER2 and estrogen receptor α depends upon nuclear localization of Y-box binding protein-1 in human breast cancers
Teruhiko Fujii et al.
CANCER RESEARCH (2008)
Low phosphorylation of estrogen receptor a (ER alpha) serine 118 and high phosphorylation of ER alpha serine 167 improve survival in ER-positive breast cancer
Hiroko Yamashita et al.
ENDOCRINE-RELATED CANCER (2008)
Codependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survival
T. S. Karin Eisinger-Mathason et al.
MOLECULAR CELL (2008)
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Anna L. Stratford et al.
BREAST CANCER RESEARCH (2008)
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi et al.
BREAST CANCER RESEARCH (2008)
The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways
Rossana Zaru et al.
NATURE IMMUNOLOGY (2007)
Phosphorylation of estrogen receptor-α at Ser167 is indicative of longer disease-free and overall survival in breast cancer patients
Jie Jiang et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of ERK-MAP kinase signaling by RSK during Drosophila development
Myungjin Kim et al.
EMBO JOURNAL (2006)
p90Rsk is not involved in cytostatic factor arrest in mouse oocytes
J Dumont et al.
JOURNAL OF CELL BIOLOGY (2005)
Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer
H Yamashita et al.
BREAST CANCER RESEARCH (2005)
Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation
GL Razidlo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development
MK Saba-El-Leil et al.
EMBO REPORTS (2003)
Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway
H Hanafusa et al.
NATURE CELL BIOLOGY (2002)
Rsk2 allosterically activates estrogen receptor α by docking to the hormone-binding domain
DE Clarkl et al.
EMBO JOURNAL (2001)
分享论文
